PERIOGARD MOUTHWASH

Nazione: Canada

Lingua: inglese

Fonte: Health Canada

Principio attivo:

CHLORHEXIDINE GLUCONATE

Commercializzato da:

COLGATE-PALMOLIVE CANADA INC

Codice ATC:

A01AB03

INN (Nome Internazionale):

CHLORHEXIDINE

Dosaggio:

0.12%

Forma farmaceutica:

MOUTHWASH

Composizione:

CHLORHEXIDINE GLUCONATE 0.12%

Via di somministrazione:

BUCCAL

Confezione:

473ML

Tipo di ricetta:

Prescription

Area terapeutica:

MISCELLANEOUS ANTI-INFECTIVES

Dettagli prodotto:

Active ingredient group (AIG) number: 0107629007; AHFS:

Stato dell'autorizzazione:

CANCELLED POST MARKET

Data dell'autorizzazione:

2022-03-30

Scheda tecnica

_Page 1 of 19_
PRODUCT MONOGRAPH
CHLORHEXIDINE GLUCONATE ORAL RINSE
Chlorhexidine Gluconate 0.12% Oral Rinse Liquid, USP
0.12% Chlorhexidine Gluconate Antigingivital Oral Rinse
Colgate-Palmolive Canada Inc.
Two Morneau Shepell Centre, 5
th
Floor,
895 Don Mills Road,
Toronto, Ontario
M3C 1W3
Submission Control No.: 207101
Date of Preparation:
August 17, 2017
_Page 2 of 19_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION.....................................................3
SUMMARY PRODUCT INFORMATION
................................................................3
INDICATIONS AND CLINICAL USE
......................................................................3
CONTRAINDICATIONS
.........................................................................................3
WARNINGS AND PRECAUTIONS
........................................................................4
ADVERSE
REACTIONS.........................................................................................6
DOSAGE AND ADMINISTRATION
........................................................................6
OVERDOSAGE
.....................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
........................................................8
STORAGE AND STABILITY
..................................................................................9
SPECIAL HANDLING INSTRUCTIONS
................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.....................................10
PART II: SCIENTIFIC INFORMATION
..........................................................................11
PHARMACEUTICAL
INFORMATION..................................................................11
CLINICAL TRIALS
................................................................................................12
DETAILED PHARMACOLOGY
............................................................................13
MICROBIOLOGY
..............................